The mechanisms of sarcopenia in T2DM patients are still complex and unclear: increased oxidative stress and reactive oxygen, insufficient protein uptake and synthesis and increased decomposition and consumption, changes in hormone levels, decreased insulin-like growth factor-1, and diabetes chronic complications [17]. This evidence concerns the gene IGF1 and type 2 diabetes mellitus.